Vortex “As a clinician, I am excited about accessing the cancer biology of patient’s through CTCs. Vortex’s technology provides the best source of CTCs to aid in the diagnostic and treatment decisions we face every day.” – Dr. Jonathan Goldman, MD, Director of Clinical Trials in Thoracic Oncology, Associate Director of Drug Development at UCLA “Improving CTCs recovery along with high cellular purity while maintaining viability have tremendous value for translational research and clinical diagnostic applications. The VTX-1 holds the potential to revolutionize blood-based diagnostics.” - Pr. Massimo Cristofanilli, MD, FACP, Professor of Medicine, Associate Director of Translational Research and Precision Medicine, Robert H Lurie Comprehensive Cancer Center, Feinberg School of Medicine Wanda J. Cribbs, Lead Gartner Analyst Population Health & Analytics says: "Wanda's recent HRS press release really stands out. Delivering those results and having a client publicly share credit with their vendor is rare and says a lot. We at Gartner will have our eyes on Wanda in 2018"

Portfolio Company CEO’s

  • Gene Walther

    Gene Walther is a senior executive with over 20 years of experience in the for-profit and global health segments focusing on diagnostics, medical devices …

    CEO of Vortex BioSciences
  • Larry Cohen

    Larry Cohen has over 30 year’s experience in the In Vitro diagnostic and medical device business. He has led large multinational businesses as well …

    CEO of Glycotest
  • Foad Dabiri

    Foad Dabiri has been the Chief Technology Officer of Wanda since March 2014, where he has been instrumental in creating Wanda’s unique cloud based …

    CEO of Wanda
  • David Ribeiro

    Dr David Ribeiro has extensive experience in commercialising products within chronic diseases, having previously held senior management roles at Solvay Healthcare, Encysive Pharmaceuticals and …

    CEO of ProAxsis
  • Frank K. Bedu-Addo, PH.D.

    Dr. Bedu-Addo is a veteran biotech executive with experience successfully starting and growing biotechnology organizations. He has been responsible for the development and implementation …

    CEO of PDS Biotechnology
Portfolio Company CEO’s - NetScientific